Epoxy resins combine high stiffness, thermal resistance, and processability but remain constrained by intrinsic brittleness. Here, a siloxane‐containing bio‐based epoxy toughener, EPMOPTSi, was synthesized from eugenol through hydrosilylation followed by epoxidation and employed to modify commercial diglycidyl ether of bisphenol A (DGEBA). Physicochemical characterizations confirmed the designed molecular structure, with a measured molecular weight of 574.86, consistent with the theoretical value. The optimized EPMOPTSi/DGEBA ratio was 1:10 (DGTSi‐2), yielding a tensile strength of 78.14 MPa, elongation at break of 14.66%, and toughness of 56.72 MJ m −3 , compared with 72.11 MPa, 11.55%, and 36.41 MJ m −3 for unmodified DGEBA. The optimized resin also exhibited a glass‐transition temperature of 87.2°C and an initial degradation temperature of 348.2°C, compared with 65.6°C and 341.0°C, respectively, for the control. Incorporation into basalt‐fiber composites further produced a tensile strength of 345.4 ± 9.6 MPa and an impact strength of 95.9 kJ m −2 . These results demonstrate an effective bio‐based strategy for simultaneously improving epoxy toughness, strength, thermal stability, and composite performance.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: